The tablets may contain N-nitrosodiethylamine, a probable human carcinogen.
The active drug ingredient was made at Hetero Labs in India, one of two drug manufacturers linked to a string of blood pressure medication recalls.
Macleods is the latest drugmaker to recall the blood pressure drug amid heightened safety concerns over the detection of the cancer-causing impurity. Major Pharmaceuticals, Teva Pharmaceuticals, Mylan and Aurobindo Pharma have also recalled blood pressure drugs in the last year.
More articles on pharmacy:
Viewpoint: It’s time for pharma to have its ‘tobacco moment’
Top 10 fatal or harmful prescribing errors
‘Wacky’ rebate system to blame for high patient drug prices, FDA chief says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.